Reduced SMAD2/3 activation independently predicts increased depth of human cutaneous squamous cell carcinoma.
Rose AM, Spender LC, Stephen C, Mitchell A, Rickaby W, Bray S, Evans AT, Dayal J, Purdie KJ, Harwood CA, Proby CM, Leigh IM, Coates PJ, Inman GJ.
Rose AM, et al. Among authors: bray s.
Oncotarget. 2018 Feb 22;9(18):14552-14566. doi: 10.18632/oncotarget.24545. eCollection 2018 Mar 6.
Oncotarget. 2018.
PMID: 29581863
Free PMC article.